Recently at a conference held by the Institute of Medicine (IOM), low participation in new clinical trials and research were discussed between industry professionals.  One viewpoint states mistrust of clinical trials, science in general and the motives of the industry are hindering recruitment.  Gaining the public’s trust and providing results could be the key to increasing participation.  To read more, go here.